ATE373468T1 - Orales spray gegen erkältungssymptome und deren dauer - Google Patents

Orales spray gegen erkältungssymptome und deren dauer

Info

Publication number: ATE373468T1
Authority: AT; Austria
Prior art keywords: duration; oral spray; zinc; against cold; cold symptoms
Prior art date: 2003-04-30

Application number

AT04751020T

Other languages

English (en)

Inventor

Tim Clarot

Original Assignee

Zicam Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-30

Filing date

2004-04-30

Publication date

2007-10-15

2004-04-30 Application filed by Zicam Llc filed Critical Zicam Llc

2007-10-15 Application granted granted Critical

2007-10-15 Publication of ATE373468T1 publication Critical patent/ATE373468T1/de

Links

201000009240 nasopharyngitis Diseases 0.000 title abstract 2
229940041678 oral spray Drugs 0.000 title abstract 2
239000000668 oral spray Substances 0.000 title abstract 2
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000011701 zinc Substances 0.000 abstract 2
229910052725 zinc Inorganic materials 0.000 abstract 2
WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 abstract 1
ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
230000002459 sustained effect Effects 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
239000004246 zinc acetate Substances 0.000 abstract 1
239000011670 zinc gluconate Substances 0.000 abstract 1
229960000306 zinc gluconate Drugs 0.000 abstract 1
235000011478 zinc gluconate Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT04751020T 2003-04-30 2004-04-30 Orales spray gegen erkältungssymptome und deren dauer ATE373468T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US46721703P	2003-04-30	2003-04-30

Publications (1)

Publication Number	Publication Date
ATE373468T1 true ATE373468T1 (de)	2007-10-15

Family

ID=33435040

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04751020T ATE373468T1 (de)	2003-04-30	2004-04-30	Orales spray gegen erkältungssymptome und deren dauer

Country Status (7)

Country	Link
US (2)	US7754763B2 (de)
EP (1)	EP1617817B1 (de)
AT (1)	ATE373468T1 (de)
AU (1)	AU2004235732B2 (de)
CA (1)	CA2524074C (de)
DE (1)	DE602004009049T2 (de)
WO (1)	WO2004098581A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9034401B1 (en)	2014-01-23	2015-05-19	Matrixx Initiatives, Inc.	Pharmaceutical compositions comprising plant extracts and methods for reducing duration of a common cold using same
DE102018205160A1 (de) *	2018-01-12	2019-07-18	Ursapharm Arzneimittel Gmbh	Nahrungsergänzungsmittel, Verwendungen hiervon, Verfahren zur Nahrungsergänzung sowie Mundspray
US12053485B2 (en)	2018-06-25	2024-08-06	Triumph Pharmaceuticals Inc.	Methods of inhibiting microbial infections using zinc-containing compositions

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4138477A (en)	1976-05-28	1979-02-06	Colgate Palmolive Company	Composition to control mouth odor
US4503070A (en)	1981-07-31	1985-03-05	Eby Iii George A	Method for reducing the duration of the common cold
US4956385A (en)	1981-07-31	1990-09-11	Eby Iii George A	Method for reducing the duration of the common cold
US5409905A (en)	1981-01-05	1995-04-25	Eby, Iii; George A.	Cure for commond cold
US5095035A (en)	1981-07-31	1992-03-10	Eby Iii George A	Flavor stable zinc acetate compositions for oral absorption
USRE33465E (en)	1981-07-31	1990-11-27		Method for reducing the duration of the common cold
US4684528A (en)	1984-06-11	1987-08-04	Godfrey Science & Design, Inc.	Flavor of zinc supplements for oral use
US4758439A (en)	1984-06-11	1988-07-19	Godfrey Science & Design, Inc.	Flavor of zinc supplements for oral use
DE3431727A1 (de) *	1984-08-29	1986-03-13	Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen	Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
US4689214A (en)	1985-04-16	1987-08-25	Colgate-Palmolive Company	Composition to counter breath odor
US5059416A (en) *	1989-06-26	1991-10-22	Warner-Lambert Company	Zinc compound delivery system with improved taste and texture
US5094845A (en)	1991-03-04	1992-03-10	David G. Vlock	Oral compositions containing zinc gluconate complexes
US5165914A (en)	1991-03-04	1992-11-24	David G. Vlock	Oral compositions containing zinc lactate complexes
MX9604411A (es)	1994-03-28	1997-12-31	Univ Columbia	Composicion para inactivar irritantes en fluidos.
AU4428397A (en)	1996-09-20	1998-04-14	Warner-Lambert Company	Oral compositions containing a zinc compound
NZ335780A (en)	1996-10-23	2001-01-26	Univ New York State Res Found	Compositions to control oral microbial oxidation-reduction (Eh) levels and treat gingivitis-periodontitis
US5897891A (en)	1996-11-18	1999-04-27	Godfrey; John C.	Flavorful zinc compositions for oral use incorporating copper
DE19818842C1 (de)	1998-04-28	2000-01-05	Suedzucker Ag	Erkältungsmittel
US6183785B1 (en)	1998-11-12	2001-02-06	Geoffrey J. Westfall	Teat disinfectant
US6169118B1 (en) *	1998-11-12	2001-01-02	Block Drug Company, Inc.	Flavor blend for masking unpleasant taste of zinc compounds
DE10124263A1 (de) *	2001-05-18	2003-01-23	Friedrich A Wetzel	Mittel zur äußerlichen Wundbehandlung, zur Behandlung von Schnupfen und zur Verwendung als Inhalationslösung
US6475526B1 (en)	2001-06-05	2002-11-05	Jeffrey B. Smith	Zinc containing compositions for anti-viral use
CA2475224C (en) *	2002-02-07	2011-11-01	The Trustees Of Columbia University In The City Of New York	Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
US20040192587A9 (en) *	2002-04-23	2004-09-30	Rosenbloom Richard A.	Zinc formulations as a prophylactic treatment for the common cold

2004
- 2004-04-30 US US10/837,078 patent/US7754763B2/en not_active Expired - Fee Related
- 2004-04-30 AT AT04751020T patent/ATE373468T1/de not_active IP Right Cessation
- 2004-04-30 WO PCT/US2004/013425 patent/WO2004098581A2/en not_active Ceased
- 2004-04-30 EP EP04751020A patent/EP1617817B1/de not_active Expired - Lifetime
- 2004-04-30 CA CA2524074A patent/CA2524074C/en not_active Expired - Fee Related
- 2004-04-30 AU AU2004235732A patent/AU2004235732B2/en not_active Ceased
- 2004-04-30 DE DE602004009049T patent/DE602004009049T2/de not_active Expired - Lifetime
2010
- 2010-07-13 US US12/835,646 patent/US8853265B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2524074C (en)	2010-03-23
AU2004235732B2 (en)	2008-04-03
WO2004098581A2 (en)	2004-11-18
US8853265B2 (en)	2014-10-07
EP1617817A2 (de)	2006-01-25
CA2524074A1 (en)	2004-11-18
US20100280106A1 (en)	2010-11-04
US20050043400A1 (en)	2005-02-24
DE602004009049T2 (de)	2008-06-19
US7754763B2 (en)	2010-07-13
DE602004009049D1 (de)	2007-10-31
WO2004098581A3 (en)	2004-12-09
EP1617817B1 (de)	2007-09-19
AU2004235732A1 (en)	2004-11-18

Similar Documents

Publication	Publication Date	Title
AU2003261167A1 (en)	2004-02-02	Liquid dosage compositions of stable nanoparticulate active agents
DE60331153D1 (de)	2010-03-18	Reboxetin enthaltende tablette mit verzögerter wirkstoffabgabe
ATE275393T1 (de)	2004-09-15	Feste dispersionen mit nitrataktiven wirkstoffen
BRPI0309457A2 (pt)	2016-06-28	composições para cuidados pessoais que contém um material contendo zinco em uma composição aquosa de tensoativo.
GT199900203A (es)	2001-11-15	Composiciones de celecoxib.
EP1506786A4 (de)	2009-07-29	Medizinische, ghrelin enthaltende zusammensetzungen
IL179250A0 (en)	2007-03-08	Stable crystal of 4-oxoquinoline compound and pharmaceutical compositions containing the same
BRPI0400721A (pt)	2004-12-07	Composições que contêm sucralose
ATE354362T1 (de)	2007-03-15	Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
JP2005526147A5 (de)	2006-01-05
ECSP078057A (es)	2008-01-23	Formulaciones de estrógenos conjugados y bazedoxifeno
EA200901393A1 (ru)	2010-02-26	Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
WO2008123582A1 (ja)	2008-10-16	テトラヒドロイソキノリン化合物
UA87841C2 (ru)	2009-08-25	Композиция, которая содержит амброксол, для местного применения
EP1962843A4 (de)	2009-08-12	Verwendung von parp-1-hemmern
PT1492773E (pt)	2009-05-07	Compostos de 4-(heterociclilo)-benzenossulfoximinapara o tratamento da inflamação
ITMI20021725A1 (it)	2002-10-31	Composizioni farmaceutiche ad attivita' antibiotica.
EP1584335A3 (de)	2006-02-22	Zusammensetzung aus Aktiva mit einer Carbinolverbindung und einem Opioid
BR9915123A (pt)	2001-07-31	Composição de uma substância farmaceuticamente ativa e dispensador
DE602004009049D1 (de)	2007-10-31	Orales spray gegen erkältungssymptome und deren dauer
DK1666473T3 (da)	2013-03-25	Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
ITMI20051417A1 (it)	2007-01-23	Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
AU2003244259A1 (en)	2004-02-25	Oral injectable pharmaceutical composition comprising florfenicol as an active ingredient
ITRM20020119A1 (it)	2003-09-05	Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
CY1110841T1 (el)	2015-06-10	Σταθεροποιημενος φαρμακευτικος παραγοντας λευκοτριενιου β4 (ltb4)

Legal Events

Date	Code	Title	Description
2008-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties